S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Laser breakthrough could send stock soaring 2,467% (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
66,000% upside on tiny biotech? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Laser breakthrough could send stock soaring 2,467% (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
66,000% upside on tiny biotech? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Laser breakthrough could send stock soaring 2,467% (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
66,000% upside on tiny biotech? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Laser breakthrough could send stock soaring 2,467% (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
66,000% upside on tiny biotech? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion

BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts

$34.00
+0.40 (+1.19%)
(As of 02/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Feb. 22)
-$0.96 Missed By -$0.09
Consensus EPS
(Feb. 22)
-$0.87
Skip Charts & View Estimated and Actual Earnings Data

BBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BridgeBio Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.84)($0.28)($0.56)
Q2 20242($0.93)($0.84)($0.89)
Q3 20242($0.97)($0.81)($0.89)
Q4 20242($1.00)($0.82)($0.91)
FY 20248($3.74)($2.75)($3.25)

BBIO Earnings Date and Information

BridgeBio Pharma last released its quarterly earnings results on February 22nd, 2024. The reported ($0.96) earnings per share for the quarter, missing the consensus estimate of ($0.87) by $0.09. The firm earned $1.74 million during the quarter, compared to the consensus estimate of $4.78 million. Its revenue for the quarter was down 8.4% compared to the same quarter last year. BridgeBio Pharma has generated ($3.94) earnings per share over the last year (($3.94) diluted earnings per share). Earnings for BridgeBio Pharma are expected to grow in the coming year, from ($3.80) to ($3.21) per share. BridgeBio Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

BridgeBio Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
2/22/2024Q4 2023($0.87)($0.96)($0.09)($0.96)$4.78 million$1.74 million
11/2/2023Q3 2023($0.86)($1.08)($0.22)($1.08)$5.29 million$4.09 million
8/3/2023Q2 2023($0.80)($0.98)($0.18)($0.98)$2.99 million$1.60 million
5/4/2023Q1 2023($0.83)($0.92)($0.09)($0.92)$3.23 million$1.83 million
2/23/2023Q4 2022($0.86)($0.87)($0.01)($0.82)$12.24 million$1.87 million
11/3/2022Q3 2022($1.02)($0.93)+$0.09($0.93)$6.26 million$0.34 million
8/4/2022Q2 2022($0.92)($0.81)+$0.11($1.55)$29.96 million$73.75 million
5/5/2022Q1 2022($1.13)($1.19)($0.06)($1.03)$4.47 million$1.69 million
2/24/2022Q4 2021($0.83)($1.01)($0.18)($1.01)$21.58 million$12.89 million    
11/4/2021Q3 2021($0.91)($1.06)($0.15)($1.06)$16.12 million$2.34 million
8/5/2021Q2 2021($0.97)($0.66)+$0.31($0.66)$24.93 million$54.00 million
5/6/2021Q1 2021($0.83)($1.18)($0.35)($1.18)$21.91 million$0.46 million  
2/24/2021Q4 2020($0.86)($1.01)($0.15)($1.01)$15.34 million$0.12 million












BridgeBio Pharma Earnings - Frequently Asked Questions

When is BridgeBio Pharma's earnings date?

BridgeBio Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on BBIO's earnings history.

Did BridgeBio Pharma beat their earnings estimates last quarter?

In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) missed the analysts' consensus estimate of ($0.87) by $0.09 with a reported earnings per share (EPS) of ($0.96). Learn more on analysts' earnings estimate vs. BBIO's actual earnings.

How much revenue does BridgeBio Pharma generate each year?

BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $9.30 million.

How much profit does BridgeBio Pharma generate each year?

BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$481.18 million. BBIO has generated -$3.94 earnings per share over the last four quarters.

What is BridgeBio Pharma's EPS forecast for next year?

BridgeBio Pharma's earnings are expected to grow from ($3.80) per share to ($3.21) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BBIO) was last updated on 2/24/2024 by MarketBeat.com Staff